** Shares of Immuron IMC.AX rise 26.2% to A$0.082, their highest since February 28
** Biopharmaceutical co reports FY25 global annual sales of A$7.3 million ($4.75 million), up 49% on y-o-y
** "In FY26, we will invest to grow in North America" - co
** Stock on track for best day since March 2024
** About 1.1 mln shares change hands, 15.1x the 30-day average of 70,880; busiest session since January 17
** Stock up 2.5% YTD, including moves in the current session
($1 = 1.5368 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。